BMO Capital analyst John Kim downgrades Sabra Health Care REIT (NASDAQ:SBRA) from Outperform to Market Perform and announces $16 price target.
BMO Capital Downgrades Sabra Health Care REIT to Market Perform, Announces $16 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.